AKT1 and glioblastoma: At the molecular level, GBM is characterized by dysregulated signaling pathways, including the phosphatidylinositol 3-kinase (PI3K)/AKT/mTOR pathway, the RAS/RAF/MAPK pathway, and the NOTCH pathway(Levine et al. 2006).